Medical Cannabis Payment Solutions (REFG) Ratios
Medical Cannabis Payment Solutions Ratios
REFG's free cash flow for Q1 2023 was $-10.96K. For the 2023 fiscal year, REFG's free cash flow was increased by $0.00 and operating cash flow was $-10.96K. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.01 | -0.67 | -0.35 | -0.89 | -4.27 |
| Operating Cash Flow Ratio | -0.00 | -0.14 | -0.26 | -0.96 | -4.84 |
| Short-Term Operating Cash Flow Coverage | -0.00 | -0.38 | -0.31 | -1.11 | -9.72 |
| Net Current Asset Value | $ -2.37M | $ -2.35M | $ -917.59K | $ -857.40K | $ -276.23K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 22.43 | 13.83 | 9.54 | 7.69 | 5.50 |
| Debt-to-Equity Ratio | -0.37 | -0.37 | -0.94 | -0.98 | -0.55 |
| Debt-to-Capital Ratio | -0.58 | -0.60 | -14.84 | -56.54 | -1.21 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.02 | -0.03 | -0.10 | -0.13 | -0.10 |
| Debt Service Coverage Ratio | -0.01 | -1.85 | -0.39 | -0.70 | -9.67 |
| Interest Coverage Ratio | 0.00 | -4170.48 | -50.75 | -490.75 | -340.71 |
| Debt to Market Cap | 0.94 | 0.45 | 0.07 | 0.35 | 0.02 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -70.40 | -0.54 | -2.52 | -1.43 | -0.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.00% | 91.80% | 65.57% | 146.13% | 393.51% |
| Return on Assets (ROA) | -89.18% | -2591.86% | -406.66% | -791.03% | -5358.99% |
| Return on Equity (ROE) | 1.47% | 70.11% | 39.95% | 101.06% | 533.66% |
| Return on Capital Employed (ROCE) | 1.47% | 76.37% | 60.92% | 69.15% | 135.62% |
| Return on Invested Capital (ROIC) | 2.32% | 122.00% | 964.99% | 3979.16% | 299.57% |
| Return on Tangible Assets | -89.18% | -2591.86% | -406.66% | -791.03% | -5358.99% |
| Earnings Yield | -3.74% | -85.26% | -3.15% | -36.38% | -16.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -80781.50 | -4.37 | -52.27 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | -80781.50 | -4.37 | -52.27 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.00 | -0.38 | -0.31 | -1.11 | -9.72 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -0.21% | -17.13% | -2.81% | -39.88% | -16.11% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -26.76 | -1.17 | -31.79 | -2.75 | -6.19 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.39 | -0.82 | -12.70 | -2.78 | -33.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -484.63 | -5.84 | -35.58 | -2.51 | -6.21 |
| Price-to-Operating Cash Flow Ratio | -484.63 | -5.84 | -43.73 | -2.56 | -6.21 |
| Price-to-Earnings Growth (PEG) Ratio | 0.28 | -0.00 | 0.49 | 0.07 | 0.07 |
| Enterprise Value Multiple | -145.30 | -1.73 | -36.62 | -5.46 | -6.30 |
| Enterprise Value | 1.77M | 2.74M | 11.39M | 3.08M | 8.44M |
| EV to EBITDA | -145.30 | -1.73 | -36.62 | -5.46 | -6.30 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -940.16 | -8.49 | -38.21 | -3.39 | -6.31 |
| EV to Operating Cash Flow | -940.16 | -8.49 | -46.95 | -3.46 | -6.31 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.03 | 1.46 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.06 | 0.20 | 0.73 | 1.08 | 1.00 |
Currency in USD
